Related references
Note: Only part of the references are listed.Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer
Kazuhito Sasaki et al.
WORLD JOURNAL OF SURGERY (2012)
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
W. Chua et al.
BRITISH JOURNAL OF CANCER (2011)
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
J. Cassidy et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
Imran Bhatti et al.
AMERICAN JOURNAL OF SURGERY (2010)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Adjuvant colon cancer chemotherapy: where we are and where we'll go
L. Lombardi et al.
CANCER TREATMENT REVIEWS (2010)
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Hideaki Shimada et al.
GASTRIC CANCER (2010)
Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
Pei-Rong Ding et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Influence of Inflammation-Based Prognostic Score on Mortality of Patients Undergoing Chemotherapy for Far Advanced or Recurrent Unresectable Colorectal Cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGERY (2009)
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
Yoji Kishi et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Treatment in advanced colorectal cancer: what, when and how?
I. Chau et al.
BRITISH JOURNAL OF CANCER (2009)
Cost Implications of New Treatments for Advanced Colorectal Cancer
Yu-Ning Wong et al.
CANCER (2009)
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
HanByoul Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
Satoshi Teramukai et al.
EUROPEAN JOURNAL OF CANCER (2009)
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
Hanne Krogh Jensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
Khaled M. Sarraf et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
Hanna K. Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma
D. Gomez et al.
WORLD JOURNAL OF SURGERY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
Hiroaki Nozawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer
J. E. M. Crozier et al.
BRITISH JOURNAL OF CANCER (2006)
K-ras activation generates an inflammatory response in lung tumors
H Ji et al.
ONCOGENE (2006)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
H Schmidt et al.
BRITISH JOURNAL OF CANCER (2005)
Systemic therapy for metastatic colorectal cancer: Current options, current evidence
H Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic significance of thrombocytosis in node-negative colon cancer
EG Kandemir et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2005)
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials
E Mitry et al.
ANNALS OF ONCOLOGY (2004)
Systemic inflammatory response predicts survival following curative resection of colorectal cancer
DC McMillan et al.
BRITISH JOURNAL OF SURGERY (2003)
Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells - Implication of inflammation-associated carcinogenesis and tumor progression
H Tazawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines:: a report from the Groupe Francais d'Immunotherapie
S Négrier et al.
ANNALS OF ONCOLOGY (2002)
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients
CH Köhne et al.
ANNALS OF ONCOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
